Provided by Tiger Trade Technology Pte. Ltd.

Alexander's

265.03
-7.2300-2.66%
Post-market: 265.030.00000.00%19:30 EDT
Volume:28.24K
Turnover:7.54M
Market Cap:1.35B
PE:8.02
High:273.82
Open:273.82
Low:263.65
Close:272.26
52wk High:289.43
52wk Low:201.28
Shares:5.11M
Float Shares:2.35M
Volume Ratio:0.98
T/O Rate:1.20%
Dividend:18.00
Dividend Rate:6.79%
EPS(TTM):33.06
EPS(LYR):5.50
ROE:92.02%
ROA:3.04%
PB:6.05
PE(LYR):48.22

Loading ...

Alexander's (ALX) Asset Sale And Target Lease Put Its Valuation In Focus

Simply Wall St.
·
Jul 16

Is Alexander's (ALX) Overvalued On Its Target Lease And Queens Asset Sale?

Simply Wall St.
·
Jul 02

ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules

GlobeNewswire
·
Jul 01

ALX Oncology Appoints New Chairman Amid Leadership Changes

TIPRANKS
·
Jul 01

ALX Oncology Appoints Scott Garland as Chairman of the Board and Michael Listgarten as General Counsel

GlobeNewswire
·
Jun 30

Alexander’s Leases 135,000 Sq Ft to Target at Rego Park Shopping Center in Queens, New York

Reuters
·
Jun 30

ALX Oncology Secures New $50 Million Loan Facility

TIPRANKS
·
Jun 27

ALX Oncology Shareholders Approve Directors and Executive Pay

TIPRANKS
·
Jun 12

Alexander's director Russell B. Wight Jr disposes of 423 common shares worth $112,941

Reuters
·
Jun 11

TriSalus Life Sciences to host virtual KOL webinar on liver cancer drug delivery evidence

Reuters
·
Jun 10

ALX Oncology to Present at the 2026 Jefferies Global Healthcare Conference in New York

GlobeNewswire
·
Jun 01

BRIEF-Alexander’S Completes Sale Of Rego Park I

Reuters
·
May 29

Alexander’s Completes Sale of Rego Park I

THOMSON REUTERS
·
May 29

Alexander’s completes sale of Rego Park I property to Northwell Health for $235.5 million

Reuters
·
May 29

Alexander’s shareholders approve 2026 omnibus stock plan at annual meeting

Reuters
·
May 22

Analysts Conflicted on These Healthcare Names: Senti Biosciences (SNTI), ALX Oncology Holdings (ALXO) and Argenx Se (ARGX)

TIPRANKS
·
May 18

Analysts’ Opinions Are Mixed on These Healthcare Stocks: ALX Oncology Holdings (ALXO) and Heron Therapeutics (HRTX)

TIPRANKS
·
May 12

ALX Oncology Holdings Q1 Adj. EPS $(0.15) Beats $(0.22) Estimate

Benzinga Earnings
·
May 08

ALX Oncology Reports First Quarter 2026 Financial Results and Provides Corporate Update

GlobeNewswire
·
May 08

ALX Oncology’s Evorpacept in Combination with Zanidatamab Generates Promising, Durable Response in Patients with Advanced HER2-Positive Breast Cancer and High CD47 Expression

GlobeNewswire
·
May 07